Logo image of AMTM

AMENTUM HOLDINGS INC (AMTM) Stock Fundamental Analysis

NYSE:AMTM - New York Stock Exchange, Inc. - US0239391016 - Common Stock - Currency: USD

22.06  +0.24 (+1.1%)

Fundamental Rating

3

AMTM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. AMTM has a bad profitability rating. Also its financial health evaluation is rather negative. AMTM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AMTM has reported negative net income.
AMTM had a positive operating cash flow in the past year.
AMTM Yearly Net Income VS EBIT VS OCF VS FCFAMTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.24%, AMTM is doing worse than 65.85% of the companies in the same industry.
With a Return On Equity value of -0.64%, AMTM is not doing good in the industry: 65.85% of the companies in the same industry are doing better.
AMTM has a worse Return On Invested Capital (2.05%) than 62.20% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMTM is significantly below the industry average of 13.48%.
Industry RankSector Rank
ROA -0.24%
ROE -0.64%
ROIC 2.05%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
AMTM Yearly ROA, ROE, ROICAMTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

Looking at the Operating Margin, with a value of 2.62%, AMTM is in line with its industry, outperforming 42.68% of the companies in the same industry.
AMTM's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 9.82%, AMTM is doing worse than 86.59% of the companies in the same industry.
In the last couple of years the Gross Margin of AMTM has declined.
Industry RankSector Rank
OM 2.62%
PM (TTM) N/A
GM 9.82%
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
AMTM Yearly Profit, Operating, Gross MarginsAMTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10

3

2. Health

2.1 Basic Checks

AMTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AMTM remains at a similar level compared to 1 year ago.
Compared to 1 year ago, AMTM has an improved debt to assets ratio.
AMTM Yearly Shares OutstandingAMTM Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M
AMTM Yearly Total Debt VS Total AssetsAMTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.38, we must say that AMTM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.38, AMTM is not doing good in the industry: 67.07% of the companies in the same industry are doing better.
The Debt to FCF ratio of AMTM is 20.96, which is on the high side as it means it would take AMTM, 20.96 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 20.96, AMTM is not doing good in the industry: 64.63% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.04 is on the high side and indicates that AMTM has dependencies on debt financing.
AMTM has a Debt to Equity ratio of 1.04. This is in the lower half of the industry: AMTM underperforms 71.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 20.96
Altman-Z 1.38
ROIC/WACC0.22
WACC9.11%
AMTM Yearly LT Debt VS Equity VS FCFAMTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.59 indicates that AMTM should not have too much problems paying its short term obligations.
The Current ratio of AMTM (1.59) is better than 60.98% of its industry peers.
AMTM has a Quick Ratio of 1.59. This is a normal value and indicates that AMTM is financially healthy and should not expect problems in meeting its short term obligations.
AMTM's Quick ratio of 1.59 is fine compared to the rest of the industry. AMTM outperforms 62.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
AMTM Yearly Current Assets VS Current LiabilitesAMTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.53% over the past year.
AMTM shows a small growth in Revenue. In the last year, the Revenue has grown by 6.65%.
Measured over the past years, AMTM shows a quite strong growth in Revenue. The Revenue has been growing by 12.53% on average per year.
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.27%
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%72.28%

3.2 Future

The Earnings Per Share is expected to grow by 74.44% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.95% on average over the next years.
EPS Next Y305.45%
EPS Next 2Y112.74%
EPS Next 3Y74.44%
EPS Next 5YN/A
Revenue Next Year2.52%
Revenue Next 2Y2.83%
Revenue Next 3Y2.95%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMTM Yearly Revenue VS EstimatesAMTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
AMTM Yearly EPS VS EstimatesAMTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

AMTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AMTM is valuated reasonably with a Price/Forward Earnings ratio of 9.19.
89.02% of the companies in the same industry are more expensive than AMTM, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.20, AMTM is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.19
AMTM Price Earnings VS Forward Price EarningsAMTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AMTM.
Based on the Price/Free Cash Flow ratio, AMTM is valued a bit cheaper than 62.20% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.03
EV/EBITDA 16.5
AMTM Per share dataAMTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

AMTM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AMTM's earnings are expected to grow with 74.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y112.74%
EPS Next 3Y74.44%

0

5. Dividend

5.1 Amount

AMTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMENTUM HOLDINGS INC

NYSE:AMTM (5/1/2025, 2:52:10 PM)

22.06

+0.24 (+1.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)05-07 2025-05-07
Inst Owners55.74%
Inst Owner Change-0.75%
Ins Owners0.55%
Ins Owner Change10.42%
Market Cap5.37B
Analysts78
Price Target24.77 (12.28%)
Short Float %5.92%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.3%
Min EPS beat(2)10.29%
Max EPS beat(2)84.31%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.24%
Min Revenue beat(2)0.09%
Max Revenue beat(2)2.38%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.69%
PT rev (3m)-20.37%
EPS NQ rev (1m)-0.21%
EPS NQ rev (3m)12.86%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)49.53%
Revenue NQ rev (1m)0.37%
Revenue NQ rev (3m)-2.95%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.19
P/S 0.55
P/FCF 24.03
P/OCF 22.36
P/B 1.2
P/tB N/A
EV/EBITDA 16.5
EPS(TTM)-0.34
EYN/A
EPS(NY)2.4
Fwd EY10.88%
FCF(TTM)0.92
FCFY4.16%
OCF(TTM)0.99
OCFY4.47%
SpS40.37
BVpS18.39
TBVpS-14.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.24%
ROE -0.64%
ROCE 2.59%
ROIC 2.05%
ROICexc 2.16%
ROICexgc 15.24%
OM 2.62%
PM (TTM) N/A
GM 9.82%
FCFM 2.27%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
ROICexc(3y)2.45%
ROICexc(5y)N/A
ROICexgc(3y)14.93%
ROICexgc(5y)N/A
ROCE(3y)2.92%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
F-Score5
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 20.96
Debt/EBITDA 8.08
Cap/Depr 5.29%
Cap/Sales 0.17%
Interest Coverage 250
Cash Conversion 41.83%
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z 1.38
F-Score5
WACC9.11%
ROIC/WACC0.22
Cap/Depr(3y)5.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.27%
EPS Next Y305.45%
EPS Next 2Y112.74%
EPS Next 3Y74.44%
EPS Next 5YN/A
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%72.28%
Revenue Next Year2.52%
Revenue Next 2Y2.83%
Revenue Next 3Y2.95%
Revenue Next 5YN/A
EBIT growth 1Y16.17%
EBIT growth 3Y11.69%
EBIT growth 5YN/A
EBIT Next Year106.14%
EBIT Next 3Y32.99%
EBIT Next 5YN/A
FCF growth 1Y-30.5%
FCF growth 3Y-45.82%
FCF growth 5YN/A
OCF growth 1Y-30.26%
OCF growth 3Y-42.49%
OCF growth 5YN/A